Patient Registry Software Market By Type (Diabetes, Cancer, Rare Diseases, CVD, Orthopedic, Drugs, Device), Delivery (On Premise, Cloud), Functionality (PHM, POC, Research), Database (Public, Commercial), Pricing Model, End User – Global Forecast To 2023

Patient Registry Software Market By Type (Diabetes, Cancer, Rare Diseases, CVD, Orthopedic, Drugs, Device), Delivery (On Premise, Cloud), Functionality (PHM, HIE, POC, Research), Database (Public, Commercial), Pricing Model, End User – Global Forecast To 2023

Patient Registry Software Market by Type (Diabetes, Cancer, Rare Diseases, CVD, Orthopedic, Drugs, Device), Delivery (On premise, Cloud), Functionality (PHM, HIE, POC, Research), Database (Public, Commercial), Pricing Model, End User - Global Forecast to 2023

Patient registry software market is slated to exhibit lucrative growth rate. Patient registry software market is expected to reach USD 1.49 billion by 2023 from USD 888.6 million in 2018, at a CAGR of 11.0% during the forecast period (2018-2023).

Succeeding an extensive secondary and primary research on patient registry software and in-depth analysis of the market scenario, the report carries out an impact analysis of the key industry drivers, restraints, opportunities, and challenges in the market dynamics segment. Continued pressure to curtail rising healthcare costs, growing demand to improve care quality, implementation of the Affordable Care Act in the U.S., trend towards value-based care, growing use of patient registry data for post-marketing surveillance, improving HCIT infrastructure and adoption of HCIT solutions such as EMRs and HIE, implementation of government initiatives to build patient registries, and rising awareness of population health management are resulting in robust demand for patient registry software across the globe. However, lack of trained/skilled resources, and privacy and data security related concern may hinder the growth of the patient registry software market to some extent.

In addition, the report further gives an extensive outlook on various end users served by the patient registry software market. These end users include government organizations & third-party administrators, hospitals and medical practices, private payers, pharmaceutical, biotechnology, and medical device companies, and research centers. Apart from end users, the report provides insights on adoption of patient registry software in various type of registries, and functionality segment of the market. Moreover, the study offers a comprehensive analysis of patient registry software market with respect to various software type, pricing model, deployment model, and database type.

Further, an in-depth analysis of the geographic scenario of the industry provides detailed qualitative and quantitative insights for the five major geographies (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa) along with the coverage of major countries in each region. The geographic analysis provides detailed insights on the key trends of the industry in the listed regions & countries, identifying the demographic & economic impact, and government & private investments. The report identifies North America being the largest market followed by Europe, Asia Pacific, and Rest of World. The geographical analysis section also comments on the key market players shaping the growth of the industry in the respective countries.

The report also includes the competitive landscape based on extensive assessment of the key strategic developments adopted by leading market participants in the industry over the past 3.5 years (2015-June 2018). The market players employed various strategies to expand their product offerings, global footprint, and augment their market share. The key strategies followed by most companies in the global patient registry software market include agreements, partnerships, & collaborations; new product launches; mergers & acquisitions; and expansion.

Some of the key players contributing to the growth of the patient registry software market include Phytel, Inc. (U.S.) (an IBM Corporation company), Quintiles IMS Holdings, Inc. (U.S.), Liaison Technologies. (U.S.), ImageTrend, Inc. (U.S.), FIGmd, Inc. (U.S.), McKesson Corporation (U.S.) (Change Healthcare), CECity.com Inc. (U.S.) (A Premier, Inc. company), Dacima Software Inc. (U.S.), Global Vision Technologies, Inc. (U.S.), ifa Systems AG, (Germany), Syneos Health (U.S.), M2S, Inc. (U.S.), Optum, Inc (A part of UnitedHealth Group Inc) (U.S.), EVADO Pty. Ltd. (Australia), and Velos, Inc. (U.S.) among several others.

Key questions answered in the report:

Hospitals and medical centers are driving the adoption of Patient Registry Software
How does the penetration of patient registry software differ among various end users?
Which are the high growth market segments in terms of registry type, software type, functionality, deployment type, database type, pricing model, and regions/countries?

Population Health Management is the fastest growing application/functionality segment of the Patient Registry Software market

What factors are propelling the growth of patient registry software market in population health management?
What factors contribute to the growth of patient registry software in medical research?

The North American region is the largest market for patient registry software and includes various global and local players competing in multiple segments

Who are the top competitors in this market and what strategies do they employ to gain shares?
Which product segments of the patient registry software market are expected to offer lucrative growth in the forecast period and why?
What strategies should the new companies focus to enter this market in order sustain and compete with the established players?
What are the major drivers, restraints, opportunities, challenges, and trends in the global patient registry software market?
What are the geographic trends and high growth regions/countries?

Recent new product launches, partnerships, agreement, expansion, acquisitions that have taken place in the patient registry software space

What companies have recently merged/acquired and how will these unions affect the competitive landscape of the patient registry software space?
What companies have created partnerships and how will these partnerships promote a competitive advantage?
Who are the major players in the global patient registry software and what share of the market do they hold?
Who are the local emerging players in the global patient registry software market and how do they compete with the global players?

Scope of the Report

Market, by Registry type

Disease Registries
Cardiovascular Registries
Diabetes Registries
Cancer Registries
Rare Disease Registries
Asthma Registries
Chronic Kidney Disease Registries
Orthopedic Registries
Others
Health Service Registries
Product Registries
Medical Device Registries
Drug Registries

Market, by Software Type

Standalone Software
Integrated Software

Market, by Pricing Model

Subscription model
Ownership model

Market, by Deployment Model

On-premise models
Web &Cloud-based models

Market, by Database Type

Commercial databases
Public databases

Market, by Functionality

Population Health Management
Patient Care Management
Health Information Exchange
Point-of-Care
Product Outcome Evaluation
Medical Research & Clinical Studies

Market, by End User

Government Organizations & Third-Party Administrators
Hospitals and Medical Practices
Private Payers
Pharmaceutical, Biotechnology, and Medical Device Companies
Research Centers

Market, by Geography

North America
U.S.
Canada
Europe
U.K.
Germany
France
Italy
Spain
Rest of Europe (RoE)
Asia-Pacific (APAC)
Japan
China
India
Rest of APAC (RoAPAC)
Latin America
Middle East & Africa